StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) stock

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.51+0.10 (+0.69%)

Close on Nov 20, 2026Market cap $36.98MP/E –Yield –

BlossomHill Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for BlossomHill Therapeutics

BlossomHill Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BlossomHill Therapeutics figures

See a number that looks wrong?